A case of lactic acidosis induced by linezolid. (Q37720394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

A case of lactic acidosis induced by linezolid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Juan Carlos Q Velez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

236-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348931%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2010.20

29 January 2020

exact match

0 references

cites work

Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Early development of lactic acidosis with short term linezolid treatment in a renal recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Structural compensation for the deficit of rRNA with proteins in the mammalian mitochondrial ribosome. Systematic analysis of protein components of the large ribosomal subunit from mammalian mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Phenformin-associated lactic acidosis: pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Structure of the Mammalian Mitochondrial Ribosome Reveals an Expanded Functional Role for Its Component Proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Mitochondrial toxicity associated with linezolid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Linezolid-induced lactic acidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Linezolid-induced lactic acidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Linezolid-induced inhibition of mitochondrial protein synthesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Lactic acidosis after treatment with linezolid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Linezolid use associated with lactic acidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

The in-depth evaluation of suspected mitochondrial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Pharmacokinetics of linezolid in subjects with renal dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.20

Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20348931